Increased Formation of Distinct F2Isoprostanes in Hypercholesterolemia
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Background—F 2 isoprostanes are stable, free radical–catalyzed products of arachidonic acid that reflect lipid peroxidation in vivo. Methods and Results—Specific assays were developed by use of mass spectrometry for the F 2 isoprostanes iPF 2α-III and iPF 2α-VI and arachidonic acid (AA). Urinary excretion of the 2 F 2 isoprostanes was significantly increased in hypercholesterolemic patients, whereas substrate AA in urine did not differ between the groups. iPF 2α-III (pmol/mmol creatinine) was elevated (P<0.0005) in homozygous familial hypercholesterolemic (HFH) patients (85±5.5; n=38) compared with age- and sex-matched normocholesterolemic control subjects (58±4.2; n=38), as were levels of iPF 2α-VI (281±22 versus 175±13;P<0.0005). Serum cholesterol correlated with urinary iPF 2α-III (r=0.41;P<0.02) and iPF 2α-VI (r=0.39;P<0.03) in HFH patients. Urinary excretion of iPF 2α-III (81±10 versus 59±4;P<0.05) and iPF 2α-VI (195±18 versus 149±20;P<0.05) was also increased in moderately hypercholesterolemic subjects (n=24) compared with their controls. Urinary excretion of iPF 2α-III and iPF 2α-VI was correlated (r=0.57;P<0.0001; n=106). LDL iPF 2α-III levels (ng/mg arachidonate) were elevated (P<0.01) in HFH patients (0.32±0.08) compared with controls (0.09±0.02). The concentrations of iPF 2-III in LDL and urine were significantly correlated (r=0.42;P<0.05) in HFH patients. Conclusions—Asymptomatic patients with moderate and severe hypercholesterolemia have evidence of oxidant stress in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study
Hertog, M. G. L., Feskens, E. J. M., Kromhout, D., Hertog, M. G. L., Hollman, P. C. H., Hertog, M. G. L., & Katan, M. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)92876-u · Cited by 4,341
急性心筋梗塞の疑いのある17187症例におけるストレプトキナーゼ静脈内投与,アスピリン経口投与,上記2つの併用または無処置の無作偽試験 ISIS-2
Dienstl, F., Backer, G. D., Cairns, J., Pedersen, F., Kala, R., Boissel, J., Schroeder, R., Horgan, J., & Tognoni, G. (1988) · The Lancet · Cited by 2,754
Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341801 · Cited by 2,397
Lipid peroxidation: its mechanism, measurement, and significance
Halliwell, B., & Chirico, S. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.5.715s · Cited by 2,352
Vitamin E Consumption and the Risk of Coronary Heart Disease in Men
Rimm, E. B., Stampfer, M. J., Ascherio, A., Giovannucci, E., Colditz, G. A., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282004 · Cited by 2,347
Stephens, N. G., Parsons, A., Brown, M. J., Schofield, P. M., Kelly, F., Cheeseman, K., & Mitchinson, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90866-1 · Cited by 2,148
Vitamin E Consumption and the Risk of Coronary Disease in Women
Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282003 · Cited by 2,103
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,978
Cited by
Keaney, J. F., Larson, M. G., Vasan, R. S., Wilson, P. W. F., Lipinska, I., Corey, D., Massaro, J. M., Sutherland, P., Vita, J. A., & Benjamin, E. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000058402.34138.11 · Cited by 1,304
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
Tangvarasittichai, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.456 · Cited by 1,213
Measurement of F2-isoprostanes as an index of oxidative stress in vivo
Roberts, L. J., & Morrow, J. D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00264-6 · Cited by 996
Oxidative Stress and Cardiovascular Injury: Part I: Basic Mechanisms and In Vivo Monitoring of ROS
Griendling, K. K., & FitzGerald, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000093660.86242.bb · Cited by 941
Self-citationIsoprostanes: markers and mediators of oxidative stress
Montuschi, P., Barnes, P. J., & Roberts, L. J. (2004) · The FASEB Journal · doi:10.1096/fj.04-2330rev · Cited by 747
Oxidative Stress and Cardiovascular Injury: Part II: Animal and Human Studies
Griendling, K. K., & FitzGerald, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000093661.90582.c4 · Cited by 721
Self-citationMorrow, J. D. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000152605.64964.c0 · Cited by 453
The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?
Witztum, J. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00111-6 · Cited by 440
Mitochondrial dysfunction in cardiovascular disease
Ballinger, S. W. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.02.014 · Cited by 405
Increased F 2 ‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo
Pratico, D., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & Fitzgerald, G. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1777 · Cited by 405
Self-citationIsoprostanes: Formation, Analysis and Use As Indices of Lipid Peroxidation in Vivo
Lawson, J. A., FitzGerald, G. A., & Rokach, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24441 · Cited by 381
Self-citationLipid peroxidation, antioxidants and cardiovascular disease: how should we move forward?
Halliwell, B. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00097-3 · Cited by 343
Oxidative stress and smoking-induced vascular injury
Burke, A., & FitzGerald, G. A. (2003) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(03)00076-8 · Cited by 276
Self-citationEffects of Vitamin E on Lipid Peroxidation in Healthy Persons
Meagher, E. A. (2001) · JAMA · doi:10.1001/jama.285.9.1178 · Cited by 270
PALINSKI, W., & NAPOLI, C. (2002) · The FASEB Journal · doi:10.1096/fj.02-0226rev · Cited by 268
F 2 -Isoprostanes in Human Health and Diseases: From Molecular Mechanisms to Clinical Implications
Basu, S. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1956 · Cited by 268
Uric acid reduces exercise-induced oxidative stress in healthy adults
WARING, W. S., CONVERY, A., MISHRA, V., SHENKIN, A., WEBB, D. J., & MAXWELL, S. R. J. (2003) · Clinical Science · doi:10.1042/cs20030149 · Cited by 256
Alcohol-induced generation of lipid peroxidation products in humans
Meagher, E. A., Barry, O. P., Burke, A., Lucey, M. R., Lawson, J. A., Rokach, J., & FitzGerald, G. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5584 · Cited by 252
Self-citationForgione, M. A., Cap, A., Liao, R., Moldovan, N. I., Eberhardt, R. T., Lim, C. C., Jones, J., Goldschmidt-Clermont, P. J., & Loscalzo, J. (2002) · Circulation · doi:10.1161/01.cir.0000026820.87824.6a · Cited by 200
Cellular glutathione peroxidase deficiency and endothelial dysfunction
Forgione, M. A., Weiss, N., Heydrick, S., Cap, A., Klings, E. S., Bierl, C., Eberhardt, R. T., Farber, H. W., & Loscalzo, J. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00598.2001 · Cited by 199
“The isoprostane iPF2 -III has been shown to be elevated in several conditions associated with endothelial dysfunction, such as diabetes mellitus (5) and hypercholesterolemia (4, 26).”
BackgroundMason, R. P., Walter, M. F., & Jacob, R. F. (2004) · Circulation · doi:10.1161/01.cir.0000129503.62747.03 · Cited by 175
F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases
Praticò, D., Rokach, J., Lawson, J., & FitzGerald, G. A. (2004) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.09.012 · Cited by 120
Self-citationOral Vitamin C Reduces Arterial Stiffness and Platelet Aggregation in Humans
Wilkinson, I. B., Megson, I. L., MacCallum, H., Sogo, N., Cockcroft, J. R., & Webb, D. J. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199911000-00010 · Cited by 117
Dietary (n-3) Fatty Acids Reduce Plasma F2-Isoprostanes but Not Prostaglandin F2α in Healthy Humans
Nälsén, C., Vessby, B., Berglund, L., Uusitupa, M., Hermansen, K., Riccardi, G., Rivellese, A., Storlien, L., Erkkilä, A., Ylä-Herttuala, S., et al. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.5.1222 · Cited by 83
Metadata
- Authors
- Reilly, M. P., Praticò, D., Delanty, N., DiMinno, G., Tremoli, E., Rader, D., Kapoor, S., Rokach, J., Lawson, J., & FitzGerald, G. A.
- Venue
- Circulation
- Published
- 1998-12-22
- Volume
- 98
- Issue
- 25
- Pages
- 2822-2828
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2079115802
- Cited by
- 271
- References
- 44
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.